Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William W. Tse
A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Interim Results of OPAL, a Study of Tosedostat in Elderly Relapsed/Refractory AML.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
Leukemia Research
Cancer Research
Oncology
Hematology
The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study
Oncotarget
Oncology
Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients With AML Evaluated Using a Simplified Multidimensional Geriatric Assessment
Advances in Therapy
Medicine
Pharmacology
